Oncolytics Biotech (ONCY) Misses Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• BlackBerry surges on earnings beat and strong cash flow
• Susquehanna lifts Micron stock target to $2,000 after record-breaking quarter